Patents by Inventor Christopher Gerding

Christopher Gerding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11912692
    Abstract: The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: February 27, 2024
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hartmut Beck, Stefanie Mesch, Alexandros Vakalopoulos, Nils Pfaff, Stefanie Zimmermann, Markus Follmann, Elisabeth Kersten, Guillaume Levilain, Kartrin Partikel, Andreas Peter Broehl, Stefan Heitmeier, Julia Dietze-Torres, Lutz Lehmann, Kersten Matthias Gericke, Frank Süßmeier, Lars Bärfacker, Alexander Hillisch, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes
  • Publication number: 20230391761
    Abstract: The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.
    Type: Application
    Filed: August 11, 2023
    Publication date: December 7, 2023
    Inventors: Hartmut Beck, Stefanie Mesch, Alexandros Vakalopoulos, Nils Pfaff, Stefanie Zimmermann, Markus Follmann, Elisabeth Kersten, Guillaume Levilain, Kartrin Partikel, Andreas Peter Broehl, Stefan Heitmeier, Julia Dietze-Torres, Lutz Lehmann, Kersten Matthias Gericke, Frank Süßmeier, Lars Bärfacker, Alexander Hillisch, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes
  • Patent number: 11375747
    Abstract: A smoking pipe is provided. The smoking pipe includes an upper housing with a lower housing removably attached to the upper housing. An insert is located between the upper housing and the lower housings so that the upper and lower housings and the insert form an interior channel that directs air introduced to the interior channel to move toward a user, then away from the user, then toward the user again.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: July 5, 2022
    Assignee: Rowdy Monkeys, LLC
    Inventor: Christopher Gerding
  • Patent number: 11046783
    Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: June 29, 2021
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas Wilmen, Julia Straßburger, Frank Dittmer, Michael Strerath, Anja Buchmüller, Joanna Grudzinska-Goebel, Ricarda Finnern, Martina Schäfer, Christoph Gerdes, Hannah Jörißen, Asako Itakura, Philberta Y. Leung, Erik Tucker
  • Publication number: 20200275691
    Abstract: A smoking pipe is provided. The smoking pipe includes an upper housing with a lower housing removably attached to the upper housing. An insert is located between the upper housing and the lower housings so that the upper and lower housings and the insert form an interior channel that directs air introduced to the interior channel to move toward a user, then away from the user, then toward the user again.
    Type: Application
    Filed: March 1, 2019
    Publication date: September 3, 2020
    Applicant: Rowdy Monkeys, LLC
    Inventor: Christopher Gerding
  • Patent number: 10221247
    Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: March 5, 2019
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Andreas Wilmen, Julia Straßburger, Frank Dittmer, Michael Strerath, Anja Buchmüller, Joanna Grudzinska-Goebel, Ricarda Finnern, Martina Schäfer, Christoph Gerdes, Hannah Jörißen, Asako Itakura, Philberta Y. Leung, Erik Tucker
  • Patent number: 10183932
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: January 22, 2019
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Strassburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes, Martina Schäfer, Tom Kinzel, Henrik Teller, Hartmut Schirok, Jürgen Klar, Eloisa Jimenez Nunez
  • Patent number: 10077265
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: September 18, 2018
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Straβburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes, Martina Schäfer, Henrik Teller, Eloisa Jiménez Núnez, Hartmut Schirok, Jürgen Klar, Mario Lobell
  • Patent number: 10040866
    Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: August 7, 2018
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas Wilmen, Julia Straßburger, Frank Dittmer, Michael Strerath, Anja Buchmüller, Joanna Grudzinska-Goebel, Ricarda Finnern, Martina Schäfer, Christoph Gerdes, Hannah Jörißen, Asako Itakura, Philberta Y. Leung, Erik Tucker
  • Patent number: 9918969
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: March 20, 2018
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Straβburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Anja Buchmüller, Christoph Gerdes, Henrik Teller, Martina Schäfer, Adrian Tersteegen
  • Patent number: 9822102
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: September 4, 2016
    Date of Patent: November 21, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Strassburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes, Martina Schäfer, Tom Kinzel, Henrik Teller, Hartmut Schirok, Jürgen Klar, Eloisa Jimenez Nunez
  • Patent number: 9783614
    Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: October 10, 2017
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas Wilmen, Julia Straβburger, Frank Dittmer, Michael Strerath, Anja Buchmüller, Joanna Grudzinska-Goebel, Ricarda Finnern, Martina Schäfer, Christoph Gerdes, Hannah Jöriβen, Asako Itakura, Philberta Leung, Erik Tucker
  • Patent number: 9765070
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: September 19, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Strassburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes, Martina Schäfer, Henrik Teller, Eloisa Jimenez Nunez, Hartmut Schirok, Jürgen Klar
  • Patent number: 9674273
    Abstract: A method for providing a service containing facilities in a peer-to-peer network comprising peer devices is provided. The peer devices may be associated with groups, each group being defined by a pre-determined facility. The pre-determined facility may be executed by each peer device associated with a respective group, and a selected peer device of a group executes the respective facility. A sequence of facilities and specifications to be executed is publicized in the peer-to-peer network, on the peer devices executing the respective facility by a peer device requesting the combined service, and the selection of the selected peer devices is carried out according to the publicized sequence and the publicized specifications.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: June 6, 2017
    Assignee: Unify GmbH & Co. KG
    Inventors: Christoph Gerdes, Vivian Prinz, Alan Southall
  • Patent number: 9607465
    Abstract: A vending machine is provided. The vending machine includes a number of bins, with each bin sized to contain a consumable product. The vending machine also includes a consumable product collection area, with the consumable product collection area accessible by a vending machine user. A conveyor communicates at least a portion of each of the bins, with the conveyor positioned to receive the consumable product from the bin and transport the consumable product to the consumable product collection area. The vending machine also includes an interface structured to receive a currency from the vending machine user to purchase at least one of the consumable products and a controller that activates the conveyor to transport the consumable product to the consumable product collection area.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: March 28, 2017
    Assignee: LAMA GROUP, LLC
    Inventors: Robert Bruck, Christopher Gerding
  • Patent number: 9493472
    Abstract: The invention relates to substituted benzoxazoles and to processes for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular disorders, preferably of thrombotic or thromboembolic disorders.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: November 15, 2016
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Swen Allerheiligen, Anja Buchmüller, Karen Engel, Christoph Gerdes, Kersten Matthias Gericke, Michael Gerisch, Stefan Heitmeier, Alexander Hillisch, Tom Kinzel, Philip Lienau, Bernd Riedl, Susanne Röhrig, Martina Victoria Schmidt, Julia Strassburger, Adrian Tersteegen
  • Patent number: 9475809
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: October 25, 2016
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Straβburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Anja Buchmüller, Christoph Gerdes, Henrik Teller, Martina Schäfer, Adrian Tersteegen
  • Patent number: 9434690
    Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: September 6, 2016
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susanne Röhrig, Alexander Hillisch, Julia Straβburger, Stefan Heitmeier, Martina Victoria Schmidt, Karl-Heinz Schlemmer, Adrian Tersteegen, Anja Buchmüller, Christoph Gerdes, Martina Schäfer, Tom Kinzel, Henrik Teller, Hartmut Schirok, Jürgen Klar, Eloisa Jimenez Nunez
  • Patent number: 9361655
    Abstract: In a method for controlling the electrical power consumption of a plurality of power consumers in a power grid, the power consumers represent network nodes of a communication network made of a plurality of network nodes, in which the power consumers communicate with each other. Each of the network nodes estimates the total power consumption of the network nodes based on the exchange of information with one other network node. Each network node having an additional power demand which increases a required amount of power, compares the total power consumption estimated by the network node plus the required amount of power to a predefined total power demand of the network nodes and initiates a delivery of the required amount of power from a power provider when the estimated total power demand thereof plus the required amount of power is less than the predefined total power demand by a threshold value.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: June 7, 2016
    Assignee: SIEMENS AKTIENGESELLSCHAFT
    Inventors: Kolja Eger, Christoph Gerdes, Gerd Voelksen
  • Patent number: D756460
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: May 17, 2016
    Assignee: LAMA GROUP, LLC
    Inventors: Robert Bruck, Christopher Gerding